Uropathy Treatment Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 4.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players.webp)
*Disclaimer: Major Players sorted in no particular order |
Uropathy Treatment Market Analysis
The Uropathy Treatment Market is expected to register a CAGR of 4.2% during the forecast period. Uropathy/obstructive uropathy may occur due to kidney stones, bladder stones, blood clots, uterine cancer, colon cancer, cervical cancer, and problems with the nerves that supply the bladder. Treatment available for management of uropathy includes stents, catheters and drugs.
According to a study published in Advances in Urology, Kidney stone disease is an increasing urological disorder of human health which is affecting about 15% of the world population and it affects all age groups but occurs more frequently in men than in women within the age of 20-49 years. Moreover, during lifetime, approximately 7% of women and 13% of men will develop a kidney stone.
Increasing prevalence of kidney stone, urological disorders and rising incidence of cancer and technological advancement in catheters and stents are the key driving factors in uropathy treatment market.
Uropathy Treatment Market Trends
This section covers the major market trends shaping the Uropathy Treatment Market according to our research experts:
Stents Segment is Expected to Hold a Major Market Share in the Uropathy Treatment Market
- A stent is a thin tube used to prevent or treat a blockage that prevents the flow of urine from the kidneys. The length of the stents used in adult patients varies between 24 and 30 cm. Additionally, stents come in differing gauges or diameters, to fit different size ureters.
- According to the American Academy of Family Physicians (AAFP), Kidney stones are a common disorder, with an annual incidence of eight cases per 1,000 adults. Moreover, around 13% of men and 7% of women develop a kidney stone in their lifetime and the overall incidence of urinary retention is 4.5 to 6.8 per 1,000 men, per year, in the United States. Moreover, the stent is used when there is a blockage in the ureter (in case of kidney stones) and allows urine to drain around the blockage and also decrease the pain associated with the blockage (i.e. kidney stone). In some cases, infection associated with the kidney stone stents helps to drain the infected urine.
- Stents segment holds a significant market share in the uropathy treatment market and is anticipated to show a similar trend over the forecast period due to the availability of specific product types according to the requirements.
- Increasing prevalence of urological disorders and technological advancement in the material used for stents are the key driving factors in the stents segment.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global uropathy treatment market due to increasing prevalence of kidney stones in this region. According to a study published in the Clinical Journal of the American Society of Nephrology, in the United States, 1 in 11 individuals will experience a urinary stone in their lifetime. In addition, the frequency of urinary stone disease (USD) in children is increasing (4%-6%) yearly, particularly among adolescents. Furthermore, the increase in technological advancements and new product launches, and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.
Uropathy Treatment Industry Overview
The Uropathy Treatment Market is fragmented competitive and consists of several major players. Some of the leading companies operating in the market include Boston Scientific Corporation, Cook Medical, Bayer AG, Sanofi, B. Braun Melsungen AG, C. R. Bard, Inc, Olympus Corporation, Teleflex Incorporated, Merit Medical Systems, Inc and Argon Medical Devices, Inc.
Uropathy Treatment Market Leaders
-
Boston Scientific Corporation
-
B. Braun Melsungen AG
-
Cook Medical
-
Bayer AG
-
Sanofi
*Disclaimer: Major Players sorted in no particular order
Uropathy Treatment Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Prevalence of Urological Disorders
-
4.2.2 Technological Advancement in the Material Used for Catheters and Stents
-
-
4.3 Market Restraints
-
4.3.1 Risk of Infection due to Stents and Catheters
-
4.3.2 Discomfort and Pain due to Stents and Catheters
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Treatment
-
5.1.1 Devices
-
5.1.1.1 Catheters
-
5.1.1.2 Stents
-
5.1.1.3 Other Devices
-
-
5.1.2 Drugs
-
-
5.2 End-user
-
5.2.1 Hospitals and Clinics
-
5.2.2 Ambulatory Surgical Centre
-
5.2.3 Other End-users
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Boston Scientific Corporation
-
6.1.2 Cook Medical
-
6.1.3 Bayer AG
-
6.1.4 Sanofi
-
6.1.5 B. Braun Melsungen AG
-
6.1.6 C. R. Bard, Inc
-
6.1.7 Olympus Corporation
-
6.1.8 Teleflex Incorporated
-
6.1.9 Merit Medical Systems, Inc
-
6.1.10 Argon Medical Devices, Inc
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Uropathy Treatment Industry Segmentation
As per the scope of the report, Uropathy is a disease of the urinary or urogenital organs that may result in the urinary related problems. Urinary system related problems include conditions such as kidney failure, urinary tract infections, kidney stones, prostate enlargement, and bladder control problems. Uropathy Treatment Market is segmented By Treatment type, End-user and Geography.
| By Treatment | |||||
| |||||
| Drugs |
| End-user | |
| Hospitals and Clinics | |
| Ambulatory Surgical Centre | |
| Other End-users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Uropathy Treatment Market Research FAQs
What is the current Uropathy Treatment Market size?
The Uropathy Treatment Market is projected to register a CAGR of 4.20% during the forecast period (2024-2029)
Who are the key players in Uropathy Treatment Market?
Boston Scientific Corporation, B. Braun Melsungen AG, Cook Medical, Bayer AG and Sanofi are the major companies operating in the Uropathy Treatment Market.
Which is the fastest growing region in Uropathy Treatment Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Uropathy Treatment Market?
In 2024, the North America accounts for the largest market share in Uropathy Treatment Market.
What years does this Uropathy Treatment Market cover?
The report covers the Uropathy Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Uropathy Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Uropathy Treatment Industry Report
Statistics for the 2024 Uropathy Treatment market share, size and revenue growth rate, created by 糖心vlog传媒鈩� Industry Reports. Uropathy Treatment analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
